Haemonetics (HAE) Capital Expenditures (2009 - 2026)

Haemonetics' Capital Expenditures history runs 18 years deep, the most recent figure standing at $17.7 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 12.9% year-over-year to $17.7 million; the TTM figure through Mar 2026 stood at $32.8 million (down 16.54% YoY), while the FY2026 annual figure was $32.8 million, down 16.54% from the prior year.
• Capital Expenditures was $17.7 million for Q1 2026 at Haemonetics, up from $6.3 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $93.1 million in Q2 2023 to a low of $3.8 million in Q2 2025.
• Historically, Capital Expenditures has averaged $20.2 million across 5 years, with a median of $12.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures jumped 226.65% in 2022, then plunged 92.82% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $16.8 million in 2022, then dropped by 13.07% to $14.6 million in 2023, then sank by 41.65% to $8.5 million in 2024, then retreated by 25.71% to $6.3 million in 2025, then surged by 178.17% to $17.7 million in 2026.
• The last three Capital Expenditures figures came in at $17.7 million (Q1 2026), $6.3 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.